CClinicalTrials.gg
CompletedNCT06904612Updated Jul 14, 2025

Using Iodized Salt to Improve Serum Folate, B12 and Iron Levels

An observational study in Neural Tube Defects, Folic Acid Deficiency and Spina Bifida, sponsored by Hydrocephalus and Neuroscience Institute. Completed at 2 sites in 2 countries. Open to female participants aged 18 Years to 45 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-07-14.

Sponsored by Hydrocephalus and Neuroscience Institute · Observational

Study type
Observational
Model
Case-only
Time perspective
Prospective
Enrollment
200
Ages
18 Years to 45 Years
Sex
Female
01

Study summary

Question: How effective is fortified iodized salt in increasing serum concentrations of folate, B12 and iron among non-pregnant and non-lactating women of reproductive age?

Hypothesis: Micronutrient fortified iodized salt can increase serum levels (of folate, B12 and iron) and serve as a policy consideration in salt fortification with both iodine and other micronutrients to reduce serious and fatal birth defects.

Read the detailed description

Salt is an ideal vehicle for fortification because its universal consumption and often centrally processed with established distribution channels. Over 70% of households globally have access to iodized salt. Considering the success of salt iodization, it is logical to use the existing infrastructure to provide folic acid and other micronutrients (such as B12 and iron) through this dietary mechanism.

AIM:To assess increase in blood concentrations of folate, B12 and iron among women of reproductive age who consume micronutrient-fortified iodized salt for 3 months.

OBJECTIVES :

  1. To examine the effect of consumption of iodized salt fortified with folic acid, B12 and iron on serum/plasma concentrations among women of reproductive age.
  2. To assess acceptance of study salt for daily use during 3 months of consumption.
02

Conditions studied

  • Neural Tube Defects
  • Folic Acid Deficiency
  • Spina Bifida
  • Anencephaly-Spina Bifida
  • B12 Deficiency Vitamin
  • Anemia
  • Iron Deficiency Anaemia Due to Dietary Causes

Keywords

  • Micronutrient deficiency
  • Food fortification
  • dietary salt
  • India
  • Folic acid
  • Neural tube defects
  • Spina Bifida
  • anencephaly
  • anemia
  • B12 deficiency
03

In context

Neural Tube Defects

49 studies on the registry are indexed under Neural Tube Defects; 11 are open to participants now.

This study's enrollment of 200 is above the median of 123 across 22 observational studies indexed under Neural Tube Defects.

Browse Neural Tube Defects studies →

Lead sponsor

This is the only study on the registry with Hydrocephalus and Neuroscience Institute as lead sponsor.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 45 Years
Sexes eligible
Female
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Women of childbearing age who are non-lactating and willing to consume the study salt for the duration were recruited for voluntary participation into the study.

Eligibility criteria

Inclusion Criteria: • Willing to voluntarily participate in the study

  • Can comprehend and comply with study requirements
  • Aged between 18 and 45 years.
  • No documented issues with child bearing potential
  • Resident of the area of study for duration of study.
  • Consume only study salt during study

Exclusion Criteria:

  • Taking multivitamins or micronutrient supplements during study
  • Pregnant or lactating at recruitment or during study
  • Co-morbidities such as Malabsorption disorders, severe anemia (Hgb \<8.0 g/dL), uncontrolled hypertension, (SBP ≥140 mm Hg or DBP ≥90 mm Hg), HIV, active TB or malaria infection
  • History of prior SBA delivery
  • Pre-existing medical conditions (i.e., cancer or need for regular medications)
05

Study design

Observational model
Case-only
Time perspective
Prospective
Enrollment
200 participants (actual)
Patient registry
No

Interventions

  • Dietary supplementMicronutrient fortified iodized salt

    addition of folic acid, B12 and iron to iodized salt to be consumed daily and assess rise in serum levels.

06

What researchers measure

Primary outcomes

  1. Measure changes in median serum folate, B12 and iron levels between baseline and study endpoint

    evaluate blood levels pre- and post-intake of study salt (fortified with folic acid, B12 and iron)

    Time frame: 2-6 months

07

Study locations

2 sites
  • Pediatric Neurosurgery
    Orlando, Florida 32827, United States
  • Andhra Medical College
    Visakhapatnam, Andhra Pradesh 530002, India
08

References and documents

Individual participant data

Plan to share: Undecided — redacted information will be made available upon request.

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 14, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06904612
Lead sponsor
Hydrocephalus and Neuroscience Institute
Collaborators
Andhra Medical College
Responsible party
Sponsor
First posted
Apr 1, 2025
Start date
Jun 1, 2022
Primary completion
Nov 30, 2022
Completion
Nov 30, 2022
Last update
Jul 14, 2025

Study contacts

Jogi Pattisapu, MD
principal investigator · Pediatric Neurosurgery

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jul 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion